T. Rowe Price Investment Management Inc. Sells 779,487 Shares of The Cooper Companies, Inc. $COO

T. Rowe Price Investment Management Inc. cut its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 7.9% in the fourth quarter, Holdings Channel reports. The institutional investor owned 9,047,117 shares of the medical device company’s stock after selling 779,487 shares during the period. T. Rowe Price Investment Management Inc.’s holdings in Cooper Companies were worth $741,502,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of COO. Root Financial Partners LLC increased its position in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the last quarter. Bell Investment Advisors Inc lifted its holdings in shares of Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Cooper Companies during the 2nd quarter worth about $36,000. True Wealth Design LLC boosted its stake in shares of Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the period. Finally, Cromwell Holdings LLC boosted its stake in shares of Cooper Companies by 128.8% during the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after purchasing an additional 273 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently weighed in on COO. Citigroup reissued a “neutral” rating and issued a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. Wells Fargo & Company restated a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research note on Wednesday, May 27th. Piper Sandler set a $86.00 price target on Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. Finally, Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target for the company. in a research note on Wednesday, March 4th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, Cooper Companies has an average rating of “Hold” and an average price target of $81.31.

Cooper Companies Price Performance

Shares of COO stock opened at $65.91 on Friday. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The stock has a market capitalization of $12.85 billion, a price-to-earnings ratio of 55.86, a P/E/G ratio of 1.70 and a beta of 0.87. The stock has a fifty day simple moving average of $64.50 and a two-hundred day simple moving average of $74.02. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter last year, the firm posted $0.96 earnings per share. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.